ERYTECH Pharma S.A. Logo

ERYTECH Pharma S.A.

Developing phage therapies to combat antibiotic-resistant bacterial infections.

ERYP | PA

Overview

Corporate Details

ISIN(s):
FR0010417360 (+2 more)
LEI:
969500U8ZZCODU8A9374
Country:
France
Address:
60 AVENUE ROCKEFELLER, 69008 LYON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PHAXIAM Therapeutics SA, formerly ERYTECH Pharma S.A., is a biopharmaceutical company developing antibacterial treatments based on bacteriophage (phage) therapy. The company focuses on combating bacterial infections, particularly those resistant to antibiotics. Its therapeutic approach utilizes phages—viruses that specifically target and destroy bacteria—to offer a highly targeted treatment for microbial infections, including multi-drug resistant strains. This represents a strategic shift from the company's former focus under the ERYTECH name, which centered on developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-18 07:00
Delisting Announcement
Informations privilégiées / Autres communiqués
French 168.4 KB
2025-06-18 07:00
Delisting Announcement
Inside Information / Other news releases
English 169.6 KB
2025-06-12 18:00
Delisting Announcement
Informations privilégiées / Autres communiqués
French 173.5 KB
2025-06-12 18:00
Delisting Announcement
Inside Information / Other news releases
English 180.8 KB
2025-06-05 07:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 116.9 KB
2025-06-05 07:00
Delisting Announcement
Inside Information / Other news releases
English 121.1 KB
2025-05-22 18:00
Delisting Announcement
Inside Information / Other news releases
English 118.8 KB
2025-05-22 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 116.6 KB
2025-05-05 07:00
Legal Proceedings Report
Inside Information / Other news releases
English 118.8 KB
2025-05-05 07:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 118.4 KB
2025-04-24 18:00
Legal Proceedings Report
Inside Information / Other news releases
English 155.0 KB
2025-04-24 18:00
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 125.4 KB
2025-03-14 17:45
Legal Proceedings Report
Inside Information / Other news releases
English 168.3 KB
2025-03-14 17:45
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 172.5 KB
2025-03-06 17:56
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 159.2 KB

Automate Your Workflow. Get a real-time feed of all ERYTECH Pharma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ERYTECH Pharma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-06-23 N/A Other Other 3,697,533 2,255,495.13 EUR
2023-06-23 N/A Other Other 71,839 43,821.79 EUR
2023-06-23 N/A Other Other 54,862 33,465.82 EUR

Peer Companies

Company Country Ticker View
EuroAPI Logo
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France EAPI
Eurobio Scientific Logo
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France ALERS
European Institute of Science AB Logo
Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.
Sweden EURI B
ExpreS2ion Biotech Holding AB Logo
Clinical-stage biotech developing vaccines and immunotherapies via a proprietary protein platform.
Sweden EXPRS2
EyeGene,Inc Logo
Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.
South Korea 185490
Faes Farma S.A. Logo
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
Spain FAE
Fagron N.V. Logo
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium FAGR
Farmak Logo
A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.
Ukraine FARM
Farmsintez ao Logo
Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.
Russian Federation LIFE
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF

Talk to a Data Expert

Have a question? We'll get back to you promptly.